Global Prescription Lens Market

Prescription Lens Market Size, Share, Growth Analysis, By Distribution Channel(Offline, Online), By Lens Coating(Anti-reflective, Scratch Resistant Coating, Anti-Fog Coating, Ultraviolet Treatment), By Application(Myopia, Hyperopia/Hypermetropia, Astigmatism, Presbyopia), By Type(Single Vision, Bifocal, Trifocal, Progressive), By Region - Industry Forecast 2025-2032


Report ID: SQSG35B2029 | Region: Global | Published Date: July, 2001
Pages: 165 | Tables: 121 | Figures: 77

Prescription Lens Market Competitive Landscape

Major players are concentrating on developing multiple kinds of prescription glasses with various coating options. These market participants are also forming partnerships and alliances in order to broaden their brand reach and enhance their product offerings. For instance, Essilor launched a progressive web app version of the pre-existing Essilor Companion for all eye care professionals. This initiative aims to simplify the digital ecosystem for Essilor's industry partners, such as Eye Care Professionals (ECPs), while also providing a better in-store digital Essilor brand experience.

Prescription Lens market Top Player's Company Profiles

  • EssilorLuxottica
  • Carl Zeiss Meditec AG
  • HOYA Corporation
  • Nikon Corporation
  • Rodenstock GmbH
  • Seiko Optical Products Co., Ltd.
  • Shamir Optical Industry Ltd.
  • Vision Service Plan
  • ZEISS International
  • Luxexcel Group BV
  • CooperVision, Inc.
  • Signet Armorlite, Inc.
  • VSP Global
  • Transitions Optical, Inc.
  • Younger Optics, Inc.
  • BBGR
  • Essilor of America, Inc.
  • Vision Ease
  • Corning Incorporated
  • Marcolin Group S.p.A.

Prescription Lens market Recent Development

  • In August 2022, Cooper Vision launched Beyond the Limbus Master training for scleral lens fitters. The series provides advanced training for intermediate and advanced scleral lens fitters, as well as basic training for support staff and ECPs.
  • In August 2022, ZEISS launched the DTI6, a thermal imaging camera with excellent image quality for identifying details in the dark and during the day. The DTI-6 has an easy-to-use interface and smart power management, making it a dependable hunting companion.
  • In August 2022, Alcon announced the acquisition of Aerie Pharmaceuticals, expanding its ophthalmic pharmaceutical portfolio.
  • In May 2022, Rodenstock acquired Indo Optical, a leading Spanish lens manufacturer, accelerating its growth in key markets.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Prescription Lens Market size was valued at USD 45.3 billion in 2019 and is poised to grow from USD 47.7 billion in 2023 to USD 66.7 billion by 2031, growing at a CAGR of 5.3% in the forecast period (2024-2031).

Major players are concentrating on developing multiple kinds of prescription glasses with various coating options. These market participants are also forming partnerships and alliances in order to broaden their brand reach and enhance their product offerings. For instance, Essilor launched a progressive web app version of the pre-existing Essilor Companion for all eye care professionals. This initiative aims to simplify the digital ecosystem for Essilor's industry partners, such as Eye Care Professionals (ECPs), while also providing a better in-store digital Essilor brand experience. 'EssilorLuxottica', 'Carl Zeiss Meditec AG', 'HOYA Corporation', 'Nikon Corporation', 'Rodenstock GmbH', 'Seiko Optical Products Co., Ltd.', 'Shamir Optical Industry Ltd.', 'Vision Service Plan', 'ZEISS International', 'Luxexcel Group BV', 'CooperVision, Inc.', 'Signet Armorlite, Inc.', 'VSP Global', 'Transitions Optical, Inc.', 'Younger Optics, Inc.', 'BBGR', 'Essilor of America, Inc.', 'Vision Ease', 'Corning Incorporated', 'Marcolin Group S.p.A.'

The prevalence of refractive error cases, primarily myopia, and astigmatism, is expected to drive the market

ZEISS is a leading manufacturer of lenses that include BlueGuard Lenses, Sunglass Lenses, Single Vision Lenses, Digital Lenses, Progressive Lenses, and Drive Safe Lenses. ZEISS is developing BlueGuard Lenses, an advanced prescription lens based on ZEISS UVProtect Technology that blocks up to 40% of potentially harmful blue light in the wavelength range of 400 nm to 455 nm. During the forecast period, the development of such a technologically advanced prescription lens is expected to boost the market growth. Furthermore, beginning in 2022, ZEISS will set a new standard of care by including full UV protection in all clear ZEISS plastic lenses.

During the forecast period, Asia-Pacific is expected to have the largest market share. China, Japan, Singapore, and the Republic of Korea are significant contributors to the region's Prescription Lens market growth. These countries account for half of the world's myopia prevalence. The region's increasing incidence of refractive errors is raising the number of patients and, as a result, the requirement for prescription lenses for their treatment. Market participants in the region are forming strategic alliances to expand their prescription lens business. Hoya announced a partnership with Orbis International, a organization that provides mentorship and training to local eye care professionals and inspires them to save sight in their communities.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Prescription Lens Market

Report ID: SQSG35B2029

$5,300
BUY NOW GET FREE SAMPLE